The macronutrient composition of the diet and glycemic control in IC
Phase 2
- Conditions
- critically ill patients.
- Registration Number
- IRCT2016111914901N9
- Lead Sponsor
- ational Nutrition and Food Technology Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Adult patients in both sexes who will be hospitalized in ICU and initiating enteral nutrition within 48 hours following the hospital admission, will be included in this study. Patients enrolled in other studies that are pregnant or with previous diabetes, hyperglycemia on admission, Body Mass Index (BMI) = 30 kg/m2, hyperlipidemia, liver failure, nephrotic syndrome and any contraindication to enteral nutrition, will be excluded. Patients who are discharge or die before the fifth day of enteral nutrition administration will be also excluded from the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The glycemic control. Timepoint: daily. Method of measurement: glucose oxidas.;Lipid profile. Timepoint: day 0 and 10. Method of measurement: ELIZA.
- Secondary Outcome Measures
Name Time Method Organ failure. Timepoint: daily. Method of measurement: clinical and paraclinical.;Length of ICU stay. Timepoint: daily. Method of measurement: observation.